Cargando…

Treating primary headaches – management of migraine

Detalles Bibliográficos
Autor principal:	Mitsikostas, Dimos D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620064/ http://dx.doi.org/10.1186/1129-2377-14-S1-O1

Ejemplares similares

O058. Cluster headache with accompanying migraine-like features
por: Taga, Arens, et al.
Publicado: (2015)

O067. Osmophobia in allodynic migraine: role of frequency of attacks and headache duration
por: Lovati, Carlo, et al.
Publicado: (2015)

O048. Chronic migraine, cluster headache or both? The suggestion of botulinum toxin
por: Ripa, Patrizia, et al.
Publicado: (2015)

Gleaning after the European Headache Federation consensus statement on refractory chronic migraine
por: Martelletti, Paolo, et al.
Publicado: (2014)

O051. Chronic migraine and onabotulinumtoxinA: a prospective study on patients treated at the Headache Centre of the Padua University and analysis of possible predictors of responsivity
por: Disco, Caterina, et al.
Publicado: (2015)

Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine
por: Kouremenos, Evangelos, et al.
Publicado: (2019)

Psychological management in chronic headache
por: Holroyd, Kenneth A
Publicado: (2013)

O005. Efficacy of oral supplement compared with amitriptyline in the prophylaxis of episodic tension-type headache and migraine without aura
por: Ciccone, Biagio, et al.
Publicado: (2015)

O059. Predictors of response to botulinum toxin for the treatment of chronic migraine: data from a Headache Center
por: Ornello, Raffaele, et al.
Publicado: (2015)

Menstrual migraine, migraine and contraceptions, migraine and pregnancy and migraine triggers
por: MacGregor, Anne
Publicado: (2013)

O018. The increased flow pulsatility into cerebral arterial network may play a role in the pathogenic mechanism of migraine headache?
por: Viola, Stefano, et al.
Publicado: (2015)

O062. Post ambulatory surgery headache in patients affected from primary headaches: a comparison with the general population
por: Manfredi, Giovanni F, et al.
Publicado: (2015)

O006. Efficacy of prophylactic therapy in chronic primary headache with use of biofeedback
por: Ciccone, Biagio, et al.
Publicado: (2015)

Guidelines for the organization of headache education in Europe: the headache school II
por: Jensen, Rigmor, et al.
Publicado: (2010)

Headache in children
por: Prabhakar, Prab
Publicado: (2013)

Treatment and outcome in medication overuse headache patients
por: Mitsikostas, D, et al.
Publicado: (2013)

New players in the preventive treatment of migraine
por: Mitsikostas, Dimos D., et al.
Publicado: (2015)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018)

Tension type headache
por: Bendtsen, Lars
Publicado: (2013)

The Role of Galcanezumab in Migraine Prevention: Existing Data and Future Directions
por: Gklinos, Panagiotis, et al.
Publicado: (2021)

Intracranial pressure guided management of patients with Chiari malformations presenting with headache: a paradigm shift?
por: Dyson, Edward W, et al.
Publicado: (2015)

Comorbidity of headache in children and adolescence
por: Wöber-Bingöl, Çiçek
Publicado: (2013)

Reflections on NICE Headache Guidelines
por: Kennis, Kay
Publicado: (2013)

Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
por: Martelletti, Paolo, et al.
Publicado: (2014)

Cluster headache: a quasi-rare disorder needing a reappraisal
por: Martelletti, Paolo, et al.
Publicado: (2015)

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Refractory Headache: One Term does Not cover All – A Statement of the European Headache Federation
por: Lampl, Christian, et al.
Publicado: (2014)

O035. Headaches in Mitochondrial Disorders
por: Vollono, Catello, et al.
Publicado: (2015)

Galcanezumab in migraine prevention: a systematic review and meta-analysis of randomized controlled trials
por: Gklinos, Panagiotis, et al.
Publicado: (2020)

O066. Kynurenine pathway metabolites in cluster headache
por: Curto, Martina, et al.
Publicado: (2015)

O065. Drug-resistant chronic cluster headache successfully treated with supraorbital plus occipital nerve stimulation. A rare case report
por: Mercieri, Marco, et al.
Publicado: (2015)

Male and female sex hormones in primary headaches
por: Delaruelle, Zoë, et al.
Publicado: (2018)

Correction to: European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Efficacy of multidisciplinary rehabilitation of patients with chronic headache
por: Gaul, C
Publicado: (2013)

O019. Headache as an emergency in children and adolescents
por: Papetti, Laura, et al.
Publicado: (2015)

Novel techniques and developments in migraine research
por: Akerman, Simon
Publicado: (2013)

O072. An uncommon case of sinusal arrest in Cluster Headache
por: De Biase, Luciano, et al.
Publicado: (2015)

O008. Improvement in clinical governance of chronic headache by an information network: HealthSOAF - Calabria Headache Network pilot study
por: Iannacchero, Rosario, et al.
Publicado: (2015)

Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome
por: Deligianni, Christina, et al.
Publicado: (2023)

Variables affecting factors associated with primary headache
por: Alexoudi, Athanasia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_losrc24tsiiave5s2ek9sof2kb